{"url":"https://lda.gov/api/v1/filings/c601154b-4236-48cb-8962-71b545f9230c/","filing_uuid":"c601154b-4236-48cb-8962-71b545f9230c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/c601154b-4236-48cb-8962-71b545f9230c/print/","filing_document_content_type":"text/html","income":"420000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Krista Hessler Carver","dt_posted":"2025-04-21T16:36:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"850 Tenth Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":11195,"url":"https://lda.gov/api/v1/registrants/11195/","house_registrant_id":31827,"name":"COVINGTON & BURLING LLP","description":"Law firm","address_1":"850 10th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS XENAKIS","contact_telephone":"+1 202-662-5846","dt_updated":"2026-07-29T10:42:26.460623-04:00"},"client":{"id":115000,"url":"https://lda.gov/api/v1/clients/115000/","client_id":467,"name":"PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Biopharmaceutical innovation and intellectual property policy issues; patent subject matter; Interagency Patent Coordination and Improvement Act of 2025 (S. 1097); Skinny Labels, Big Savings Act (S. 43); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":154132,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":"DAVID","last_name":"LAZEROW","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64759,"prefix":null,"prefix_display":null,"first_name":"KRISTA","nickname":null,"middle_name":null,"last_name":"CARVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98248,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"DERZKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":119967,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20900,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"L","last_name":"PLITSCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Proposed amendments to the Inflation Reduction Act (P.L. 117-169); Give Kids a Chance Act of 2025 (H.R. 1262/S. 932); Stop STALLING Act (S. 1095); approval pathways; S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes; biosimilar testing; S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes; Interagency Patent Coordination and Improvement Act of 2025 (S. 1097); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); EPIC Act of 2025 (S. 832); H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Innovation in Pediatric Drugs Act of 2025 (S. 705); biosimilar policy issues; Skinny Labels, Big Savings Act (S. 43).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64759,"prefix":null,"prefix_display":null,"first_name":"KRISTA","nickname":null,"middle_name":null,"last_name":"CARVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":119967,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"STERN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98248,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"DERZKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20900,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"L","last_name":"PLITSCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154132,"prefix":"mr","prefix_display":"MR.","first_name":"ANDREW","nickname":null,"middle_name":"DAVID","last_name":"LAZEROW","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}